fipamezole

DRUG2 trials

Sponsors

Juvantia Pharma Ltd

Conditions

Multiple System AtrophyParkinson's DiseaseSymptomatic Neurogenic Orthostatic Hypotension (NOH)

Phase 2

Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease

CompletedNCT00559871

Juvantia Pharma LtdParkinson's Disease

Start: 2007-10-31End: 2009-05-31Updated: 2009-06-03

Fipamezole in Neurogenic Orthostatic Hypotension

Juvantia Pharma LtdMultiple System Atrophy, Parkinson's Disease, Symptomatic Neurogenic Orthostatic Hypotension (NOH)

Start: 2008-09-30End: 2009-05-31Target: 24Updated: 2008-10-01